Triamterene 50 mg / benzthiazide 25 mg Oral Capsule
RxNorm 104245
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 104245 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: triamterene 50 mg / benzthiazide 25 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Benzthiazide 25 mg / triamterene 50 mg Oral Capsule
(Atom ID: 12330214)
PT
Designated preferred name (PT):
Benzthiazide 25 mg and triamterene 50 mg oral capsule
(Atom ID: 10294872)
FN
Full form of descriptor (FN):
Product containing precisely benzthiazide 25 mg and triamterene 50 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10309811)
PSN